Avalo Therapeutics
AVTX
#8070
Rank
NZ$0.65 B
Marketcap
NZ$12.16
Share price
-6.98%
Change (1 day)
-61.00%
Change (1 year)

Market capitalization of Avalo Therapeutics (AVTX)

Market cap: NZ$0.65 Billion

As of October 2026 Avalo Therapeutics has a market cap of NZ$0.65 Billion. This makes Avalo Therapeutics the world's 8070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avalo Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.65 B12.3%
2025NZ$0.58 B320.76%
2024NZ$0.13 B1096.04%
2023NZ$11.53 M-84.57%
2022NZ$74.73 M-73.38%
2021NZ$0.28 B2.29%
2020NZ$0.27 B-22.74%
2019NZ$0.35 B80.78%
2018NZ$0.19 B67.38%
2017NZ$0.11 B897.16%
2016NZ$11.77 M-72.19%
2015NZ$42.33 M

End of Day market cap according to different sources

On Oct 23rd, 2026 the market cap of Avalo Therapeutics was reported to be:

NZ$0.65 Billion
by Nasdaq info icon info icon
NZ$0.65 Billion
by CompaniesMarketCap info icon info icon